Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 21 ... as a safety valve for arresting the viral infection in the presence of the pro-drug, ganciclovir," wrote M. Bauzon and colleagues, Bayer Healthcare. The researchers ...
2009 AUG 10 ... adoptive transfer of autologous CMV-specific T cells to a lung transplant recipient with ganciclovir-resistant CMV-pneumonia requiring mechanical ventilation. Infused T cells rapidly ...
2009 JUL 20 ... Transplantation report. "received a minimum of 14 days of postoperative ganciclovir, followed by monthly CMV PCR monitoring. Forty-three CMV seronegative recipients ...
2009 NOV 9 ... 5 mg/d). Recent history included acute CMV infection, which was treated with ganciclovir. Basal serum cortisol concentration was 4 mu g/dL, and stimulated serum cortisol ...
2009 JUL 27 ... cancer tumor xenografts in mice by in vivo PEI system. The antitumor effects of HSV-tk/ganciclovir (GCV) system were observed after intraperitoneal injection of GCV. Histological analysis ...
2009 AUG 3 ... 3 consecutive days with Ad5.SSTR/TK.RGD or control buffer with or without the prodrug ganciclovir (GCV) and euthanized on day 4,19, or 56," scientists writing in the journal Clinical ...
2009 AUG 3 ... with the viral vector induced cell death in glioblastoma cell lines in the presence of ganciclovir (GCV), but did not affect the survival of human astrocytes and neurons. In a mouse ...
2009 OCT 5 ... kinase (TK). DHFR confers resistance to methotrexate (MTX) and TK confers sensitivity to ganciclovir (GCV). Modified cells were also transduced with green fluorescent protein and parental ...
2009 AUG 17 ... to a study from Istanbul, Turkey, "Valganciclovir is an L-valyl ester pro-drug of ganciclovir that was initially used to treat cytomegalovirus (CMV)-associated retinitis in patients ...
2009 AUG 31 ... to radiation than ACC-2 cells when exposed to 5-fluorocytosine (5-FC; 40 mu g/ml) plus ganciclovir (0.1 mu g/ml) for 48 h before irradiation." "Analysis of radiation ...
2009 NOV 16 ... virus-1-thymidine kinase (TK), which kills proliferating tumor cells in the presence of ganciclovir. This treatment induced immunological memory that led to rejection of a second ...
2009 AUG 31 ... of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors' new ...
2009 AUG 31 ... Researchers detail in 'MLH1 deficiency enhances tumor cell sensitivity to ganciclovir,' new data in cancer gene therapy. "Suicide gene therapy with herpes simplex virus ...
2009 SEP 14 ... "Information is limited on long-term outcomes after preemptive use of ganciclovir to control cytomegalovirus (CMV) infection in lung transplantation. We studied 78 lung ...
2009 SEP 28 ... and Drug Administration (FDA) has approved its New Drug Application for Zirgan™ (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). ...
2009 AUG 24 ... "Valganciclovir (VGC) is an oral prodrug of ganciclovir (GCV) recently introduced for prophylaxis and treatment of cytomegalovirus infection. ...
2009 NOV 9 ... P = .007) after controlling for baseline viral load, CMV serostatus at baseline, ganciclovir resistance, and antiviral treatment. No effect of gB genotype was seen on virologic or ...
2009 NOV 2 ... University. The researchers concluded: "He was treated with intravenous ganciclovir, with no further hematochezia." Lim and colleagues published their study ...
